| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.TRIPLEO.2005.08.018 |
| P698 | PubMed publication ID | 16360607 |
| P2093 | author name string | Poramate Pitak-Arnnop | |
| Jean-Paul Meningaud | |||
| Jacques-Charles Bertrand | |||
| Luc Chikhani | |||
| P2860 | cites work | The use of transdermal scopolamine to control drooling. A case report | Q28332849 |
| Intraductal laser photocoagulation of the bilateral parotid ducts for reduction of drooling in patients with cerebral palsy | Q30983574 | ||
| Long-term follow-up of submandibular duct rerouting for the treatment of sialorrhea in the pediatric population | Q33538056 | ||
| Bilateral submandibular duct relocation for drooling: an evaluation of results for the Birmingham Children's Hospital | Q35042049 | ||
| Success and complications of four-duct ligation for sialorrhea | Q35057411 | ||
| Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis | Q35457770 | ||
| Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders | Q35461798 | ||
| A systematic review for evidence of efficacy of anticholinergic drugs to treat drooling | Q35538621 | ||
| Surgical management of sialorrhea | Q38263844 | ||
| Outcomes of submandibular duct relocation: a 15-year experience | Q39387151 | ||
| Use of atropine eye drops for clozapine induced hypersalivation | Q73321981 | ||
| Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism | Q73472804 | ||
| Outcomes of submandibular duct re-implantation for sialorrhoea | Q73772663 | ||
| Quantitative assessment of parkinsonian sialorrhea and results of treatment with botulinum toxin | Q73853124 | ||
| An experimental study of bilateral repositioning of the Stensen's duct orifices with autologous vein and artery grafts in dogs | Q73950007 | ||
| Bilateral submandibular gland excision with parotid duct ligation for treatment of sialorrhea in children: long-term results | Q74460366 | ||
| Recurrent jaw dislocation after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis | Q74561333 | ||
| A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease | Q75246324 | ||
| External radiation of the parotid glands significantly reduces drooling in patients with motor neurone disease with bulbar paresis | Q77060683 | ||
| The role of radiation therapy in the management of sialorrhea | Q77156332 | ||
| Nebulized scopolamine in the management of oral dribbling: three case reports | Q77326585 | ||
| Botulinum toxin to reduce saliva flow: selected indications for ultrasound-guided toxin application into salivary glands | Q77523272 | ||
| Results of radiotherapy for drooling in amyotrophic lateral sclerosis | Q77996065 | ||
| Four-duct ligation: a simple and effective treatment for chronic aspiration from sialorrhea | Q78001662 | ||
| Bilateral parotid-duct diversion using autologous vein grafts for the management of chronic drooling in cerebral palsy | Q78649982 | ||
| Surgical treatment of seizures from the peri-Sylvian area by perinatal insult: a case report of ictal hypersalivation | Q80514301 | ||
| Salivary production in Parkinson's disease | Q80609764 | ||
| Botulinum toxin injections for children with excessive drooling | Q81582364 | ||
| Treatment of the drooling child by submandibular duct transposition | Q93634755 | ||
| Surgical management of drooling in the neurologically damaged child | Q39523712 | ||
| The role of the cerebral cortex in swallowing | Q40839425 | ||
| The surgical treatment of drooling. A ten-year review | Q41034327 | ||
| Long-Term Follow-Up of Tympanic Neurectomy for Sialorrhea | Q41696688 | ||
| The effect of chorda tympani section on ipsilateral and contralateral salivary secretion and taste in man. | Q42107290 | ||
| Botulinum toxin for the treatment of sialorrhoea in ALS: serious side effects of a transductal approach | Q43071341 | ||
| Botulinum toxin is a useful treatment in excessive drooling in saliva | Q43072247 | ||
| Transtympanic neurectomy: a solution to drooling problems. | Q43941598 | ||
| Castillo-Morales' Orofacial Therapy: Treatment of 67 Children with Down Syndrome | Q43975776 | ||
| Clinical assessment of dysphagia in early phases of Parkinson's disease | Q44138230 | ||
| Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study. | Q44237904 | ||
| Up-to-date report of botulinum toxin therapy in patients with drooling caused by different etiologies | Q44396674 | ||
| Botulinum toxin as an effective treatment of clozapine-induced hypersalivation | Q44745562 | ||
| Scolpolamine patch for clozapine-induced sialorrhea | Q44787084 | ||
| Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial. | Q45041174 | ||
| Substrate recognition strategy for botulinum neurotoxin serotype A. | Q46801352 | ||
| Traditional Chinese medicine (tongue acupuncture) in children with drooling problems | Q47615627 | ||
| Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy | Q47943480 | ||
| Ultrasound-guided versus 'blind' intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease | Q47995531 | ||
| Surgery of sialorrhoea | Q48439118 | ||
| Surgical treatment of drooling | Q48574522 | ||
| Intracellular activity of motoneurons of the rostral nucleus ambiguus during swallowing in sheep | Q50112097 | ||
| Botulinum toxin A as a treatment for excessive drooling in children. | Q51954029 | ||
| Experience with the Wilkie procedure for sialorrhea. | Q52055902 | ||
| Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series. | Q52129827 | ||
| Management of drooling in individuals with neurodisability: a surgical experience. | Q52133820 | ||
| Control of Drooling with Transdermal Scopolamine in a Child with Cerebral Palsy | Q52235273 | ||
| Biofeedback techniques and behaviour modification in the conservative remediation of drooling by children with cerebral palsy. | Q52257884 | ||
| The surgical treatment of drooling in Leicester: 12 years experience. | Q52864676 | ||
| The surgical management of drooling--a 15 year follow-up. | Q53595830 | ||
| Botulinum toxin B reduces sialorrhea in parkinsonism | Q53855033 | ||
| Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. | Q53879895 | ||
| A randomized trial of botulinum toxin A for treatment of drooling | Q60360007 | ||
| Moebius syndrome with oral involvement | Q63197800 | ||
| Botulinum toxin A as treatment for drooling saliva in PD | Q64806268 | ||
| Treatment of drooling in Parkinson's disease with botulinum toxin | Q64819942 | ||
| Tympanic Neurectomy and Chorda Tympanectomy for the Control of Drooling | Q67324642 | ||
| Treatment of uncontrolled drooling by bilateral excision of submaxillary glands and parotid duct ligations | Q67383065 | ||
| The role of a saliva control clinic in the management of drooling | Q67548942 | ||
| On the bad effects of nerve sections for the control of drooling | Q67662927 | ||
| Treatment of drooling by parotid duct ligation and submandibular duct diversion | Q68031889 | ||
| Submandibular Duct Retroposition Reduces Drooling, but May Cause Caries in Lower Front Teeth | Q68169169 | ||
| Reduction of Salivary Flow with Scopoderm Tts | Q68306234 | ||
| Submandibular duct relocation for drooling: a 10-year experience with 194 patients | Q69217598 | ||
| Toxic psychosis from transdermal scopolamine in a child | Q69889039 | ||
| Submandibular gland resection and bilateral parotid duct ligation as a management for chronic drooling in cerebral palsy | Q69950208 | ||
| Long-term results of submandibular duct transposition for drooling | Q70136538 | ||
| Transtympanic neurectomies for control of drooling | Q70638838 | ||
| A non-surgical method of reducing drooling in cerebral-palsied children | Q71238962 | ||
| The effect of submandibular duct rerouting in the treatment of sialorrhea in children | Q71571941 | ||
| Long-term outcome of saliva-control surgery | Q71816884 | ||
| Prevalence and severity of feeding and nutritional problems in children with neurological impairment: Oxford Feeding Study | Q73207554 | ||
| P433 | issue | 1 | |
| P921 | main subject | saliva | Q155925 |
| P304 | page(s) | 48-57 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics | Q15763254 |
| P1476 | title | Drooling of saliva: a review of the etiology and management options | |
| P478 | volume | 101 |
| Q47301186 | Access to special care dentistry, part 8. Special care dentistry services: seamless care for people in their middle years - part 2. |
| Q41843170 | Accuracy of Ultrasound-Guided and Non-ultrasound-Guided Botulinum Toxin Injection Into Cadaver Salivary Glands |
| Q50778776 | Accurate assessment of drooling severity with the 5-minute drooling quotient in children with developmental disabilities. |
| Q38269292 | An update on the use of botulinum toxin therapy in Parkinson's disease |
| Q83176735 | Anatomical localization of submandibular gland for botulinum toxin injection |
| Q36910243 | Behavioral treatment of drooling: a methodological critique of the literature with clinical guidelines and suggestions for future research |
| Q37928736 | Botox(®) to reduce drooling in a paediatric population with neurological impairments: a Phase I study |
| Q59153428 | Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease |
| Q37492682 | Botulinum toxin in the treatment of drooling in tetraplegic patients with brain injury |
| Q58125409 | Botulinum toxin type A for the treatment of sialorrhoea in amyotrophic lateral sclerosis: A clinical and neurophysiological study |
| Q53157757 | Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis. |
| Q38263839 | Cerebral palsy: a dental update. |
| Q38981704 | Dental health of children with cerebral palsy |
| Q90042362 | Drooling in Parkinson's Disease: Prevalence and Progression from the Non-motor International Longitudinal Study |
| Q33871524 | Endoscope-assisted submandibular sialadenectomy: a review of outcomes, complications, and ethical concerns. |
| Q37077356 | Evidence for the effectiveness of botulinum toxin for sialorrhoea |
| Q37889470 | Gastrointestinal symptoms in Parkinson disease: clinical aspects and management. |
| Q37922214 | Iatrogenic injury of the chorda tympani: a systematic review |
| Q24234533 | Interventions for drooling in children with cerebral palsy |
| Q34863754 | Management of drooling for patients in the north of Iran: Analysis of the surgical management |
| Q33906343 | Management of drooling in disabled patients with scopolamine patches. |
| Q42775401 | Oral Health and Swallowing Problems |
| Q41620551 | Outpatient Treatment Based on Self-Management Strategies for Chronic Drooling in Two Children. |
| Q33768467 | RimabotulinumtoxinB in sialorrhea: systematic review of clinical trials |
| Q38132235 | Safety and administration of treatment with botulinum neurotoxin for sialorrhoea in ALS patients: review of the literature and a proposal for tailored treatment |
| Q38260089 | Saliva management options for difficult-to-wean people with tracheostomy following severe acquired brain injury (ABI): A review of the literature. |
| Q26777907 | Salivary Secretory Disorders, Inducing Drugs, and Clinical Management |
| Q44000779 | Salivary parameters in Brazilian individuals with cerebral palsy who drool |
| Q64069595 | Sialorrhea in patients with ALS: current treatment options |
| Q37330300 | Sialorrhoea and drooling in patients with Parkinson's disease: epidemiology and management |
| Q37663865 | Sublingual administration of atropine eyedrops in children with excessive drooling - a pilot study |
| Q47553482 | The Correlation Between Clinical Characteristics and Radionuclide Salivagram Findings in Patients With Brain Lesions: A Preliminary Study |
| Q36470373 | The association of drooling and health-related quality of life in children with cerebral palsy |
| Q91831435 | The burden of sialorrhoea in chronic neurological conditions: current treatment options and the role of incobotulinumtoxinA (Xeomin®) |
| Q34250597 | The management of gastrointestinal symptoms in Parkinson's disease |
| Q28085416 | The ontogeny of saliva secretion in infants and esophagoprotection |
| Q38543693 | The role of radiation therapy in the management of sialorrhea: A systematic review. |
| Q24234650 | Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis |
| Q24243640 | Treatment for sialorrhea in people with motor neuron disease or amyotrophic lateral sclerosis |
| Q51617879 | Treatment of severe drooling with botulinum toxin in amyotrophic lateral sclerosis and Parkinson's disease: efficacy and possible mechanisms. |
Search more.